{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:24:57Z","timestamp":1778930697741,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ijrobp.2010.09.018","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T04:46:54Z","timestamp":1292474814000},"page":"184-190","source":"Crossref","is-referenced-by-count":53,"title":["Phase I Trial of Pelvic Nodal Dose Escalation With Hypofractionated IMRT for High-Risk Prostate Cancer"],"prefix":"10.1016","volume":"82","author":[{"given":"Jarrod B.","family":"Adkison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek R.","family":"McHaffie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren M.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Khuntia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G.","family":"Petereit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.09.018_bib1","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1200\/JCO.2003.05.004","article-title":"Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413","volume":"21","author":"Roach","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ijrobp.2007.04.003","article-title":"An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone\/radiation interactions","volume":"69","author":"Lawton","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0360-3016(88)90225-8","article-title":"Elective pelvic irradiation in stage A2, B carcinoma of the prostate: Analysis of RTOG 77-06","volume":"15","author":"Asbell","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib4","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1200\/JCO.2006.10.5171","article-title":"Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01","volume":"25","author":"Pommier","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2007.10.008","article-title":"Radiotherapy after prostatectomy: Is the evidence for dose escalation out there?","volume":"71","author":"King","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2007.09.047","article-title":"Improved outcomes with higher doses for salvage radiotherapy after prostatectomy","volume":"71","author":"King","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0360-3016(90)90559-3","article-title":"Minimization of small bowel volume within treatment fields utilizing customized \u201cbelly boards\u201d","volume":"19","author":"Shanahan","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0b013e3181976614","article-title":"Hypofractionation for prostate cancer","volume":"15","author":"Ritter","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0090-4295(01)01441-8","article-title":"Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium","volume":"58","author":"Partin","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/02841860600781781","article-title":"Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy","volume":"45","author":"Hong","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.08.002","article-title":"RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer","volume":"74","author":"Lawton","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","article-title":"Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma: Long-term results of phase III RTOG 85-31","volume":"61","author":"Pilepich","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/JCO.2007.13.9881","article-title":"Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610","volume":"26","author":"Roach","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib15","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1200\/JCO.2007.14.9021","article-title":"Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer","volume":"26","author":"Horwitz","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib17","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1097\/01.ju.0000091805.98960.13","article-title":"A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer","volume":"170","author":"Cagiannos","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0022-5347(17)35239-4","article-title":"Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer","volume":"151","author":"Bluestein","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib19","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.eururo.2007.01.108","article-title":"Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection","volume":"51","author":"Briganti","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2006.01.043","article-title":"Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy","volume":"49","author":"Briganti","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0022-5347(01)69077-3","article-title":"Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma","volume":"167","author":"Conrad","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0022-5347(05)64670-8","article-title":"Is a limited lymph node dissection an adequate staging procedure for prostate cancer?","volume":"168","author":"Bader","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0022-5347(05)65177-4","article-title":"Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis","volume":"167","author":"Heidenreich","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urology.2006.09.008","article-title":"Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy","volume":"69","author":"Briganti","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-5347(17)56906-2","article-title":"Extended pelvic lymphadenectomy for prostatic cancer","volume":"121","author":"Golimbu","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0302-2838(02)00243-9","article-title":"Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph\u00a0node dissection","volume":"42","author":"Burkhard","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-5347(05)64055-4","article-title":"Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer","volume":"169","author":"Clark","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2008.07.053","article-title":"Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era","volume":"74","author":"Nguyen","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib29","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1056\/NEJMoa022749","article-title":"Noninvasive detection of clinically occult lymph-node metastases in prostate cancer","volume":"348","author":"Harisinghani","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1148\/radiol.2512071018","article-title":"Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging","volume":"251","author":"Heesakkers","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib31","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijrobp.2008.10.050","article-title":"Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer","volume":"75","author":"McCammon","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib33","doi-asserted-by":"crossref","unstructured":"Kavanagh BD, Pan CC, Dawson LA, et\u00a0al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys xxx;76:S101\u2013S107.","DOI":"10.1016\/j.ijrobp.2009.05.071"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib34","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1200\/JCO.2003.11.023","article-title":"Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02","volume":"21","author":"Hanks","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.018_bib35","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610033262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610033262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:51Z","timestamp":1559865651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610033262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0360301610033262"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.09.018","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}